Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00513721 · ClinicalTrials.gov registry record

Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy

A clinical trial, sponsored by Corewell Health East.

Completed
Registry status
400
Enrollment target

NCT00513721: Completed study, sponsored by Corewell Health East.

NCT00513721 is a clinical trial that has completed, run by Corewell Health East. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00513721 has completed, sponsored by Corewell Health East.

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

This is a review of prostate biopsy specimens which show capsular penetration or positive surgical margins. Patients had surgery performed at William Beaumont Hospital-Royal Oak, Michigan.

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2007-07
Est. Completion 2009-05
Corewell Health East

106 total trials

What the finished NCT00513721 record still lists

NCT00513721 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00513721 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00513721 about?

NCT00513721 is a clinical study titled "Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy". This is a review of prostate biopsy specimens which show capsular penetration or positive surgical margins. Patients had surgery performed at William Beaumont Hospital-Royal Oak, Michigan.

What is the current status of trial NCT00513721?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2007-07. Estimated completion is 2009-05.

Who is sponsoring clinical trial NCT00513721?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00513721, the US trial registry maintained by the National Library of Medicine. NCT00513721 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.